Jackson Wealth Management LLC Decreases Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Jackson Wealth Management LLC decreased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 14.1% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 677 shares of the healthcare conglomerate’s stock after selling 111 shares during the quarter. Jackson Wealth Management LLC’s holdings in UnitedHealth Group were worth $342,000 at the end of the most recent quarter.

Other hedge funds also recently added to or reduced their stakes in the company. AMF Tjanstepension AB lifted its stake in UnitedHealth Group by 88.0% in the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock valued at $151,374,000 after buying an additional 121,180 shares during the last quarter. Czech National Bank raised its position in UnitedHealth Group by 7.3% in the 3rd quarter. Czech National Bank now owns 188,110 shares of the healthcare conglomerate’s stock valued at $109,984,000 after purchasing an additional 12,721 shares during the last quarter. Hudson Value Partners LLC grew its position in UnitedHealth Group by 8.3% during the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the last quarter. Versant Capital Management Inc boosted its stake in shares of UnitedHealth Group by 17.8% during the third quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock worth $591,000 after buying an additional 153 shares during the period. Finally, Ignite Planners LLC raised its position in UnitedHealth Group by 11.2% during the 3rd quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock worth $791,000 after buying an additional 136 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.6 %

NYSE UNH opened at $545.08 on Wednesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company’s fifty day moving average price is $535.03 and its two-hundred day moving average price is $565.09. The company has a market capitalization of $501.63 billion, a price-to-earnings ratio of 35.17, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the prior year, the company posted $5.83 EPS. The business’s revenue was up 6.8% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on UNH shares. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company cut their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Truist Financial reduced their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Piper Sandler lowered their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

Insider Activity

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.